{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:58:36Z","timestamp":1787065116699,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005187","name":"University of Athens","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by slowly progressive degeneration of upper motor neurons (UMNs) and lower motor neurons (LMNs). Although the pathogenesis of sporadic form of ALS has not been fully elucidated, the initial damage mostly leads to hyperexcitability of the central and peripheral motor neuron. The results of our study aimed to confirm the changes in the excitability of the peripheral motor axon and contribute to the emergence of these measurements as potential biomarkers for disease progression. A total of 56 ALS patients [24 women (43%), median age 62.5 (interquartile range: 53.75\u201370.25) years] were finally included in the study. Twenty-four healthy controls that were age- and sex-matched to the cases [12 women (50%), mean age 58.46\u2009\u00b1\u20098.84] were recruited. The first main finding of our study is the fact that abnormalities of the voltage gated K\n                    <jats:sup>+<\/jats:sup>\n                    ion channels were constantly present in ALS patients than in the controls. The multivariate analysis revealed that Superexcitability 7ms lower than \u2212\u200921.06%, related to shorter survival. Additionally using receiver operating characteristic (ROC) curves, the c-statistic showed Superexcitability 7ms moderate predictive ability. The clinical significance of our results is that Superexcitability 7ms can be used as a biomarker not only for survival but also for disease progression.\n                  <\/jats:p>","DOI":"10.1007\/s10072-025-08443-w","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T04:11:42Z","timestamp":1756095102000},"page":"5847-5853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Motor neuron axonal excitability changes in the clinical course of amyotrophic lateral sclerosis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-0049","authenticated-orcid":false,"given":"Panagiotis","family":"Kokotis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Bakola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schmelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Rentzos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Papagiannopoupou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"5","key":"8443_CR1","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/S1474-4422(21)00465-8","volume":"21","author":"SA Goutman","year":"2022","unstructured":"Goutman SA, Hardiman O, Al-Chalabi A, Chi\u00f3 A, Savelieff MG, Kiernan MC, Feldman EL (2022) Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol May; 21(5):480\u2013493","journal-title":"Lancet Neurol"},{"issue":"4","key":"8443_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3390\/ph15040433","volume":"15","author":"K Shibuya","year":"2022","unstructured":"Shibuya K, Otani R, Suzuki Y-i, Kuwabara S, Kiernan MC (2022) Neuronal hyperexcitability and free radical toxicity in amyotrophic lateral sclerosis: established and future targets. Pharmaceuticals 15(4):433. https:\/\/doi.org\/10.3390\/ph15040433","journal-title":"Pharmaceuticals"},{"issue":"1","key":"8443_CR3","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","volume":"22","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio H, Matosin N, Ooi L (2022) Neuronal hyperexcitability in alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry Jun 22(1):257","journal-title":"Transl Psychiatry Jun"},{"issue":"1","key":"8443_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s13311-016-0492-9","volume":"14","author":"SB Park","year":"2017","unstructured":"Park SB, Kiernan MC, Vucic S (2017) Axonal Excitability in Amyotrophic LateralSclerosis\u202f: Axonal Excitability in ALS. Neurotherapeutics 14(1):78\u201390","journal-title":"Neurotherapeutics"},{"issue":"2","key":"8443_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","volume":"21","author":"H Bostock","year":"1998","unstructured":"Bostock H, Cikurel K, Burke D (1998) Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve Feb; 21(2):137\u2013158","journal-title":"Muscle Nerve"},{"issue":"7","key":"8443_CR6","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp-2011-301782","volume":"83","author":"K Kanai","year":"2012","unstructured":"Kanai K, Shibuya K, Sato Y, Misawa S, Nasu S, Sekiguchi Y, Mitsuma S, Isose S, Fujimaki Y, Ohmori S, Koga S, Kuwabara S (2012) Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry Jul 83(7):734\u2013738","journal-title":"J Neurol Neurosurg Psychiatry Jul"},{"key":"8443_CR7","doi-asserted-by":"publisher","unstructured":"Otani R, Shibuya K, Suzuki Y et al (2024) Effects of motor cortical and peripheral axonal hyperexcitability on survival in amyotrophic lateral sclerosis journal of neurology, neurosurgery & psychiatry published online first: 28 February. https:\/\/doi.org\/10.1136\/jnnp-2023-333039","DOI":"10.1136\/jnnp-2023-333039"},{"issue":"6","key":"8443_CR8","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1152\/jn.00174.2023","volume":"130","author":"A Lugg","year":"2023","unstructured":"Lugg A, Schindle M, Sivak A, Tankisi H, Jones KE (2023) Nerve excitability measured with the TROND protocol in amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurophysiol 130(6):1480\u20131491","journal-title":"J Neurophysiol"},{"issue":"Pt 2","key":"8443_CR9","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/brain\/114.2.843","volume":"114","author":"JA Kiernan","year":"1991","unstructured":"Kiernan JA, Hudson AJ (1991) Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. Brain Apr 114(Pt 2):843\u2013853","journal-title":"Brain Apr"},{"issue":"9","key":"8443_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S1388-2457(01)00595-8","volume":"112","author":"D Burke","year":"2001","unstructured":"Burke D, Kiernan MC, Bostock H (2001) Excitability of human axons. Clin Neurophysiol Sep 112(9):1575\u20131585","journal-title":"Clin Neurophysiol Sep"},{"issue":"Pt 4","key":"8443_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/brain\/awl024","volume":"129","author":"K Kanai","year":"2006","unstructured":"Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, Sawai S, Hattori T, Bostock H (2006) Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain Apr; 129(Pt 4):953\u2013962","journal-title":"Brain"},{"issue":"Pt 1","key":"8443_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1093\/brain\/118.1.217","volume":"118","author":"H Bostock","year":"1995","unstructured":"Bostock H, Sharief MK, Reid G, Murray NM (1995) Axonal ion channel dysfunction in amyotrophic lateral sclerosis. Brain Feb 118(Pt 1):217\u2013225","journal-title":"Brain Feb"},{"issue":"1","key":"8443_CR13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13041-023-01070-6","volume":"15","author":"RN Stringer","year":"2023","unstructured":"Stringer RN, Weiss N (2023) Pathophysiology of ion channels in amyotrophic lateral sclerosis. Mol Brain Dec 15(1):82","journal-title":"Mol Brain Dec"},{"issue":"7","key":"8443_CR14","doi-asserted-by":"publisher","first-page":"e0158596","DOI":"10.1371\/journal.pone.0158596","volume":"11","author":"Y Iwai","year":"2016","unstructured":"Iwai Y, Shibuya K, Misawa S, Sekiguchi Y, Watanabe K, Amino H et al (2016) Axonal dysfunction precedes motor neuronal death in amyotrophic lateral sclerosis. PLoS ONE 11(7):e0158596. 10.1371","journal-title":"PLoS ONE"},{"key":"8443_CR15","doi-asserted-by":"publisher","unstructured":"Rana MM, Sarwar MG, Alam SKM, Raknuzzaman M, Shafiq S, Khan MN, Rahman ZH, Miah MBA, Hasan M, Hasan MA, Hossain MRZ (2025) CMAP amplitude of median Nerve - A prognostic marker of amyotrophic lateral sclerosis. South East Eur J Public Health 94\u2013100. https:\/\/doi.org\/10.70135\/seejph.vi.6030","DOI":"10.70135\/seejph.vi.6030"},{"key":"8443_CR16","doi-asserted-by":"publisher","first-page":"5379","DOI":"10.1113\/JP276624","volume":"596","author":"J Howells","year":"2018","unstructured":"Howells J, Matamala JM, Park SB, Garg N, Vucic S, Bostock H, Burke D, Kiernan MC (2018) In vivo evidence for reduced ion channel expression in motor axons of patients with amyotrophic lateral sclerosis. J Physiololy 596:5379\u20135396. https:\/\/doi.org\/10.1113\/JP276624","journal-title":"J Physiololy"},{"issue":"12","key":"8443_CR17","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1016\/j.clinph.2012.06.020","volume":"123","author":"BC Cheah","year":"2012","unstructured":"Cheah BC, Lin CS, Park SB, Vucic S, Krishnan AV, Kiernan MC (2012) Progressive axonal dysfunction and clinical impairment in amyotrophic lateral sclerosis. Clin Neurophysiol Dec 123(12):2460\u20132467. https:\/\/doi.org\/10.1016\/j.clinph.2012.06.020Epub 2012 Aug 23. PMID: 22921484","journal-title":"Clin Neurophysiol Dec"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08443-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08443-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:02:14Z","timestamp":1760983334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08443-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":17,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["8443"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08443-w","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors did not receive support from any organization for the submitted work. The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent according to the Declaration of Helsinki was obtained from all participants and the study was approved by the local ethics committee (Aeginition hospital).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors report no disclosures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}